119 related articles for article (PubMed ID: 24691740)
1. MG132 reverse the malignant characteristics of hypopharyngeal cancer.
Ma J; Yu L; Tian J; Mu Y; Lv Z; Zou J; Li J; Wang H; Xu W
Mol Med Rep; 2014 Jun; 9(6):2587-91. PubMed ID: 24691740
[TBL] [Abstract][Full Text] [Related]
2. FaDu cell characteristics induced by multidrug resistance.
Ma J; Lu S; Yu L; Tian J; Li J; Wang H; Xu W
Oncol Rep; 2011 Nov; 26(5):1189-95. PubMed ID: 21833476
[TBL] [Abstract][Full Text] [Related]
3. MG‑132 reverses multidrug resistance by activating the JNK signaling pathway in FaDu/T cells.
Ma J; Lv Z; Liu X; Liu X; Xu W
Mol Med Rep; 2018 Aug; 18(2):1820-1825. PubMed ID: 29901180
[TBL] [Abstract][Full Text] [Related]
4. [Role of ABCB1 and ABCG2 in the multidrug resistance of hypopharyngeal carcinoma FaDu cell line].
MA JK; LU SM; YU L; TIAN JJ; LI JF; WANG HB; XU W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):305-10. PubMed ID: 22800348
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo.
Ren X; Liu H; Zhang M; Wang M; Ma S
Mol Med Rep; 2016 Sep; 14(3):2431-8. PubMed ID: 27484725
[TBL] [Abstract][Full Text] [Related]
6. [Reversion of resistance to cisplatin induced by MG132 in cervical cancer line HCE1 multicellular spheroid].
Wu YL; Yang HJ; Wang KK; Tao GS; Liu YZ; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):287-91. PubMed ID: 20646542
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a.
Qiang W; Sui F; Ma J; Li X; Ren X; Shao Y; Liu J; Guan H; Shi B; Hou P
Endocrine; 2017 Apr; 56(1):98-108. PubMed ID: 28220348
[TBL] [Abstract][Full Text] [Related]
8. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G
Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues].
Han J; Tan BB; Geng W; Lu BR; Zhao JH
Ai Zheng; 2008 Nov; 27(11):1166-71. PubMed ID: 19000447
[TBL] [Abstract][Full Text] [Related]
10. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance.
Fujita T; Washio K; Takabatake D; Takahashi H; Yoshitomi S; Tsukuda K; Ishibe Y; Ogasawara Y; Doihara H; Shimizu N
Int J Cancer; 2005 Nov; 117(4):670-82. PubMed ID: 15945097
[TBL] [Abstract][Full Text] [Related]
12. Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling.
Zhang Y; Yang B; Zhao J; Li X; Zhang L; Zhai Z
Med Sci Monit; 2018 Jan; 24():294-304. PubMed ID: 29332931
[TBL] [Abstract][Full Text] [Related]
13. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
14. The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells.
Kong D; Ma S; Liang B; Yi H; Zhao Y; Xin R; Cui L; Jia L; Liu X; Liu X
Biomed Pharmacother; 2012 Jun; 66(4):271-8. PubMed ID: 22564245
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
[TBL] [Abstract][Full Text] [Related]
16. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.
Biskup E; Kamstrup MR; Manfé V; Gniadecki R
Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp.
Zhang Y; Shi Y; Li X; Du R; Luo G; Xia L; Du W; Chen B; Zhai H; Wu K; Fan D
Cancer Biol Ther; 2008 Apr; 7(4):540-6. PubMed ID: 18296917
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]